A detailed history of Gsa Capital Partners LLP transactions in Zynex Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 79,930 shares of ZYXI stock, worth $624,253. This represents 0.05% of its overall portfolio holdings.

Number of Shares
79,930
Previous 46,281 72.71%
Holding current value
$624,253
Previous $431,000 51.28%
% of portfolio
0.05%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$7.19 - $10.31 $241,936 - $346,921
33,649 Added 72.71%
79,930 $652,000
Q2 2024

Aug 15, 2024

BUY
$8.63 - $12.56 $399,405 - $581,289
46,281 New
46,281 $431,000
Q4 2023

Feb 16, 2024

BUY
$7.1 - $10.89 $316,532 - $485,497
44,582 Added 39.41%
157,699 $1.72 Million
Q3 2023

Nov 15, 2023

BUY
$6.95 - $9.89 $149,960 - $213,396
21,577 Added 23.57%
113,117 $904,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $185,303 - $314,088
21,572 Added 30.83%
91,540 $877,000
Q1 2023

May 12, 2023

BUY
$9.53 - $16.8 $666,795 - $1.18 Million
69,968 New
69,968 $839,000
Q2 2022

Aug 09, 2022

SELL
$5.78 - $8.87 $375,202 - $575,787
-64,914 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$5.14 - $9.35 $184,515 - $335,646
35,898 Added 123.72%
64,914 $404,000
Q4 2021

Feb 14, 2022

BUY
$8.71 - $13.77 $252,729 - $399,550
29,016 New
29,016 $289,000
Q1 2021

May 10, 2021

SELL
$12.28 - $19.74 $186,668 - $300,067
-15,201 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$11.65 - $17.94 $195,580 - $301,176
-16,788 Reduced 52.48%
15,201 $205,000
Q3 2020

Nov 06, 2020

BUY
$12.98 - $25.98 $415,217 - $831,074
31,989 New
31,989 $558,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $293M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.